Distribution of C-peptide and its determinants in North American children at risk for type 1 diabetes

Ping Xu1, Xiaoning Qian2, Desmond A Schatz3

  • 1Pediatrics Epidemiology Center, College of Medicine, University of South Florida, Tampa, FL ping.xu@epi.usf.edu.

Diabetes Care
|April 25, 2014
PubMed

Insights

Age, BMI, and sex influence C-peptide levels in North American children at risk for type 1 diabetes (T1D). These factors are crucial for establishing C-peptide percentiles in T1D prevention trials.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Immunology

Background:

  • Type 1 diabetes (T1D) risk assessment in children requires understanding normal C-peptide levels.
  • C-peptide, a marker of insulin production, varies with age, body mass index (BMI), and sex.

Purpose of the Study:

  • To establish normative basal and stimulated C-peptide percentiles for North American children and adolescents at risk for T1D.
  • To identify demographic and clinical factors influencing C-peptide distribution within the Diabetes Prevention Trial-Type 1 (DPT-1) cohort.

Main Methods:

  • Analysis of 582 participants (aged 4-18) from the DPT-1 trials.
  • Oral glucose tolerance tests (OGTT) conducted at baseline and every 6 months over 5 years.
  • Conditional quantile regression used to model C-peptide percentiles against age, BMI Z-score (BMIZ), and sex.

Main Results:

  • Basal and stimulated C-peptide levels significantly increased with age and BMIZ (P < 0.05).
  • Age and BMIZ showed a greater impact on upper C-peptide quartiles.
  • Girls exhibited higher stimulated C-peptide levels than boys at similar ages and BMIZ (P < 0.05).
  • HLA type and autoantibody profiles did not significantly affect C-peptide distribution after adjustments.

Conclusions:

  • Age-, sex-, and BMIZ-specific C-peptide percentiles can be reliably estimated for at-risk pediatric populations.
  • These established percentiles can serve as valuable assessment tools for T1D prevention trials.
Abstract

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17